- |||||||||| buprenorphine transdermal / Generic mfg.
Clinical, Journal: Rapid Induction Therapy for Opioid-Use Disorder Using Buprenorphine Transdermal Patch: A Case Series. (Pubmed Central) - May 13, 2021 We believe that this approach can be used in a wide range of patients to transition from opioid use to buprenorphine therapy without the patient having to experience withdrawal or wait to start treatment. This should reduce the risk of lack of return for follow-up as well as decrease the dropout rate caused by patients being unable to tolerate withdrawal symptoms.
- |||||||||| buprenorphine transdermal / Generic mfg.
Trial completion, Trial completion date: Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair (clinicaltrials.gov) - Apr 8, 2021 P2/3, N=50, Completed, This should reduce the risk of lack of return for follow-up as well as decrease the dropout rate caused by patients being unable to tolerate withdrawal symptoms. Recruiting --> Completed | Trial completion date: May 2019 --> Apr 2021
|